SCHEMBL18376591

SCHEMBL18376591

COCOc1ccc(Nc2ncc3cccc(-c4ccc(OC)cc4)c3n2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK10 P53779 8/20 0.54
▸ EGFR P00533 1/20 0.52
▸ JUN P05412 5/20 0.50
▸ CCNA2 P20248 1/20 0.47
▸ CDK2 P24941 1/20 0.47
▸ TTK P33981 1/20 0.47
▸ PTK2 Q05397 2/20 0.47
▸ CDK4 P11802 1/20 0.46
▸ CCND1 P24385 1/20 0.46
▸ CCND2 P30279 1/20 0.46
▸ CCND3 P30281 1/20 0.46
▸ AURKA O14965 1/20 0.45
▸ SYK P43405 1/20 0.45
▸ KDR P35968 3/20 0.44
▸ RIPK2 O43353 2/20 0.44
▸ NOD2 Q9HC29 1/20 0.44
▸ MAPK8 P45983 2/20 0.44
▸ CDK1 P06493 2/20 0.44
▸ JAK2 O60674 1/20 0.44
▸ JAK3 P52333 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29370804 1.00 MAPK10 (0.54) MAPK10EGFRJUNCCNA2CDK2
SCHEMBL29371294 0.93 MAPK10 (0.60) MAPK10EGFRJUNCCNA2CDK2
SCHEMBL18376750 0.93 MAPK10 (0.60) MAPK10EGFRJUNCCNA2CDK2
SCHEMBL29371938 0.88 MAPK10 (0.55) MAPK10EGFRJUNCCNA2CDK2
SCHEMBL18377036 0.88 MAPK10 (0.55) MAPK10EGFRJUNCCNA2CDK2
SCHEMBL29372241 0.87 PIK3CA (0.57) MAPK10EGFRJUNCCNA2CDK2
SCHEMBL18377045 0.87 PIK3CA (0.57) MAPK10EGFRJUNCCNA2CDK2
SCHEMBL18377054 0.86 EGFR (0.52) MAPK10EGFRJUNCCNA2CDK2
SCHEMBL29371112 0.86 EGFR (0.52) MAPK10EGFRJUNCCNA2CDK2
SCHEMBL18377037 0.84 MAPK10 (0.54) MAPK10EGFRJUNCCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 — — CN claimed
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 — — CN disclosed
CN-106316965-B Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2021-08-27 — — CN disclosed
WO-2017005137-A1 QUINAZOLINE COMPOUND, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USES THEREOF 吉林大学 2017-01-12 — — WO disclosed
Send feedback